116 related articles for article (PubMed ID: 23387809)
21. [New aspects of nephroblastoma (Wilms tumor) and other metanephrogenic neoplasms].
Harms D; Schmidt D; Leuschner I
Verh Dtsch Ges Pathol; 1989; 73():350-71. PubMed ID: 2482620
[TBL] [Abstract][Full Text] [Related]
22. Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor.
Williams RD; Al-Saadi R; Natrajan R; Mackay A; Chagtai T; Little S; Hing SN; Fenwick K; Ashworth A; Grundy P; Anderson JR; Dome JS; Perlman EJ; Jones C; Pritchard-Jones K
Genes Chromosomes Cancer; 2011 Dec; 50(12):982-95. PubMed ID: 21882282
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
24. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
25. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
26. Brain metastasis of Wilms tumor with diffuse anaplasia and complex cytogenetic phenotype in a child with neurofibromatosis Type 1.
Shvartsbeyn M; Bassani L; Mikolaenko I; Wisoff JH
J Neurosurg Pediatr; 2011 Oct; 8(4):353-6. PubMed ID: 21961578
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotype, mRNA expression, and gene structure of p53 in Wilms' tumors.
el Bahtimi R; Hazen-Martin DJ; Re GG; Willingham MC; Garvin AJ
Mod Pathol; 1996 Mar; 9(3):238-44. PubMed ID: 8685221
[TBL] [Abstract][Full Text] [Related]
28. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
[TBL] [Abstract][Full Text] [Related]
29. Single-nucleotide polymorphism in WT1 gene in a hyperplastic intralobar nephrogenic rest with botryoid protrusion.
Mizuno K; Hayashi Y; Tozawa K; Iwatsuki S; Kojima Y; Kohri K
Urology; 2010 Jul; 76(1):149-52. PubMed ID: 19914700
[TBL] [Abstract][Full Text] [Related]
30. Nephroblastic neoplasms.
Khoury JD
Clin Lab Med; 2005 Jun; 25(2):341-61, vi-vii. PubMed ID: 15848740
[TBL] [Abstract][Full Text] [Related]
31. Precursor lesions of Wilms' tumor in Indian children: a multiinstitutional study.
Mishra K; Mathur M; Logani KB; Kakkar N; Krishna A
Cancer; 1998 Nov; 83(10):2228-32. PubMed ID: 9827730
[TBL] [Abstract][Full Text] [Related]
32. Amplification and expression of EGFR and ERBB2 in Wilms tumor.
Vasei M; Modjtahedi H; Ale-Booyeh O; Mosallaei A; Kajbafzadeh AM; Shahriari M; Ghaderi AA; Soleymanpour H; Kosari F; Moch H; Sauter G
Cancer Genet Cytogenet; 2009 Oct; 194(2):88-95. PubMed ID: 19781441
[TBL] [Abstract][Full Text] [Related]
33. Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.
Fukuzawa R; Heathcott RW; More HE; Reeve AE
J Clin Pathol; 2007 Sep; 60(9):1013-6. PubMed ID: 17172473
[TBL] [Abstract][Full Text] [Related]
34. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
35. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors.
Ramachandran C; Melnick SJ; Escalon E; Jhabvala P; Khatib Z; Alamo A; Smith S
Anticancer Res; 2000; 20(5C):3759-65. PubMed ID: 11268451
[TBL] [Abstract][Full Text] [Related]
36. New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience.
Vujanić GM; Harms D; Sandstedt B; Weirich A; de Kraker J; Delemarre JF
Med Pediatr Oncol; 1999 May; 32(5):317-23. PubMed ID: 10219330
[TBL] [Abstract][Full Text] [Related]
37. Vincristine, Irinotecan, and Bevacizumab in Relapsed Wilms Tumor With Diffuse Anaplasia.
Schiavetti A; Varrasso G; Collini P; Clerico A
J Pediatr Hematol Oncol; 2018 May; 40(4):331-333. PubMed ID: 28859044
[TBL] [Abstract][Full Text] [Related]
38. Bloom syndrome in sibs: first reports of hepatocellular carcinoma and Wilms tumor with documented anaplasia and nephrogenic rests.
Jain D; Hui P; McNamara J; Schwartz D; German J; Reyes-Múgica M
Pediatr Dev Pathol; 2001; 4(6):585-9. PubMed ID: 11826367
[TBL] [Abstract][Full Text] [Related]
39. An overview of the clinical and molecular genetics of Wilms' tumor.
Grundy P; Coppes M
Med Pediatr Oncol; 1996 Nov; 27(5):394-7. PubMed ID: 8827064
[No Abstract] [Full Text] [Related]
40. TP53 codon 72 polymorphisms in favorable histology Wilms tumors.
Cost NG; Mitui M; Khokhar S; Wickiser JE; Baker LA; Rakheja D
Pediatr Blood Cancer; 2012 Aug; 59(2):326-8. PubMed ID: 22052810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]